ArticleImatinib Mesylate–Induced Lichenoid Drug EruptionAuthor:Hye Jin Chung, MDPublish date: March 6, 2017Imatinib mesylate (imatinib) is a tyrosine kinase inhibitor initially approved by the US Food and Drug Administration in 2001 for chronic myeloid l...Read More
ArticleRupioid Psoriasis and Other Skin Diseases With Rupioid ManifestationsAuthor:Hye Jin Chung, MDPublish date: September 5, 2014 The term rupioid has been used to describe well-demarcated, cone-shaped plaques with thick, dark, lamellate, and adherent crusts on the skin that ...Read More
